← Back to search results

plannedFind a Tender · planning

NEXT GENERATION SEQUENCING SOLUTION - PIN

Buyer: Procurement and Logistics Service →

BuyerProcurement and Logistics Service
Statusplanned
DeadlineNot published
ValueValue not published
Published14 Nov 2024

What is being bought

This is a Prior Information Notice published by the Business Services Organisation (BSO), Procurement and Logistics Service (PaLS) (the Authority), on behalf of our Client - the Belfast Health and Social Care Trust (BHSCT), to enter into pre-market engagement with interested suppliers, as PaLS are commencing work for the provision of a solution for next generation sequencing for the Regional Molecular Diagnostics Service (RMDS) which includes: Genetics, Haematology, Microbiology and Histocompatibility and Immunogenetics Laboratories based in the BHSCT.

Delivery location

UKN

Categories

Medical equipments, pharmaceuticals and personal care products 33000000

Lot details

Lot 1

This is a Prior Information Notice published by the Business Services Organisation (BSO), Procurement and Logistics Service (PaLS) (the Authority), on behalf of our Client - the Belfast Health and Social Care Trust (BHSCT), to enter into pre-market engagement with interested suppliers, as PaLS are commencing work for the provision of a solution for next generation sequencing for the Regional Molecular Diagnostics Service (RMDS) which includes: Genetics, Haematology, Microbiology, Histocompatibility and Immunogenetics Laboratories based in the BHSCT. The RMDS offers services for Germline and Somatic testing to improve diagnosis, treatment options and management of patients with cancer, haematological conditions and rare genetic disorders. The germline service is divided into Constitutional Cytogenetics and Molecular Genetics, and the somatic service consists of a solid tumour and hematological malignancies section. The objectives of the Product Awareness Sessions are to: - * Gain initial supplier interest in supply and delivery / provision of the Next Generation Sequence Solution. * Seek interested parties to complete a site visit to RMDS to view current arrangements and floorplans. * Gain insight on the market possibilities and potential innovative solutions. * Establish how market ready suppliers currently are. * Ascertain how suppliers can assist the HSCNI to ensure Health and Safety Standards are met and to ensure compliance with all relevant and future legislation. * Understand risks and potential issues relating to supply and delivery of Next Generation Sequence Solution. * Gain a better understanding of the feasibility of the HSCNI requirements and the most appropriate procurement approach to follow. Additional information: Site Visits: Interested suppliers are requested to visit the client site and is mandatory to understand the client’s infrastructure at the site. Advance arrangement is necessary. The Client has limited capacity to facilitate site visits; therefore, places will be restricted and it may not be possible to accommodate all interested suppliers. Sessions will be allocated on a first come first served basis. Market Engagement Questionnaire: Any interested suppliers are asked to complete and submit the associated questionnaire.. The Product Awareness Sessions will be an opportunity for suppliers to present to a panel of Next Generation Sequencing professionals. Interested suppliers will be invited to a product awareness session. This session will be scheduled to last approximately 60 minutes per presenting organisation and presenters will be required to:- a) Provide a video demonstration of the physical and practical functioning of the proposed solution. This video should last no more than 10 minutes. b) Provide an oral presentation on their equipment, testing capabilities and software to attendees, including IT connectivity capabilities. c). To be available for responding to questions or clarifications from those in attendance following the presentation, covering all aspects of system operation, connectivity, installation, commissioning, training, and after-sales servicing, including contingency services. The oral presentation will be scheduled to last approximately 30 minutes per presenting organisation, and should cover all aspects of functionality, including testing capabilities, turnaround time, throughput, sample processing, compatibility of sample and media types, consumables, quality management, ICT connectivity, software, aftersales support, and contingency. The participating organisations should be available for questions or clarification from those in attendance following the oral presentation, covering all aspects of system operation, connectivity, installation, commissioning, training, and after-sales servicing, including contingency services. Product awareness sessions are scheduled to take place in person, on Wednesday 15th & Friday 17th January 2025. It is likely that the Client will only be able to facilitate 2 days of supplier engagement sessions; therefore,. places will be limited, and it may not be possible to accommodate all interested suppliers. Sessions will be allocated on a first come first served basis. The venue for the product awareness session will be at Belfast City Hospital. To register interest, interested suppliers must complete the Declaration of interest form in Appendix 2, as detailed in the Declaration of Interest document once requested. Specific appointment times will be communicated to each supplier following this date.. What you need to do now: . a) If not registered on eTendersNI, do so on the website www.eTendersNI.gov.uk Go to the 'Suppliers new to eTendersNI' section and follow the registration process. Potential tenderers will be required to register against the relevant CPV codes applicable to them to ensure they receive email alerts regarding specific areas of interest. If already registered. b) Potential tenderers should review their contact details to ensure the information is up to date. Assistance is available from eTendersNI Helpdesk, telephone number: 08002404545.. c) Declare your interest in this Supplier engagement exercise by sending an email to palsgransha.sourcing@hscni.net requesting a Declaration of Interest pack.. d) Complete the Declaration of Interest form Appendix 1. e) Submit your completed Declaration of Interest form Appendix 1 by email to palsgransha.sourcing@hscni.net before the deadline at 15.00 hrs Thursday 28th November 2024.. f) Ensure that you will be available to attend site visits W.C. 9th December 2024. g) Complete the Declaration of Interest form Appendix 2 to participate in Product Awareness Session. h) Submit your completed Declaration of Interest form Appendix 2 to participate in Product Awareness Session before the deadline at 15:00 hrs Thursday 19th December 2024.. i) Complete the Market Engagement Questionnaire form. j) Submit the Market Engagement Questionnaire form by 15:00 on Thursday 19th December 2024.. k) Ensure that you will be available to attend the Supplier product awareness Session(s) on Wednesday 15th January 2025 and Friday 17th January 2025 in Belfast City Hospital and be able to present..

Statusplanned

What is included

ItemCategoryQuantity
1Not publishedNot published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 33. The category anchor is Medical equipments, pharmaceuticals and personal care products (33000000); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison setProceduresReported bids per procedureNamed award suppliersPrice evidence
Market: CPV division 334,8542 median · 122.5 average (2,278 of 4,854 with a bid count)5.8 average (2,724 of 4,854 with named award suppliers)Not published
Same buyer6010 median · 42.3 average (38 of 60 with a bid count)7.6 average (38 of 60 with named award suppliers)Not published
Delivery region: UKN5221 median · 21.3 average (395 of 522 with a bid count)3.3 average (455 of 522 with named award suppliers)Not published

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Price-outcome signal

Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.

Procurement strategy & market signals

Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleNot published
Rationale classificationsNot published
Special regimeNot published
Covered byGPA
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published

Planning & early market engagement

BudgetNot published
No-engagement rationaleNot published
Planning documents0
Planning milestones0

No planning milestones published.

Related procurements

No linked framework, prior procurement or reprocurement published.

Documents & submission route

No documents are published in the current source record.

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCIDocds-h6vhtk-04b679
Latest release ID036869-2024
Latest release timestampThu Nov 14 2024 14:41:45 GMT+0000 (Coordinated Universal Time)
Sourcefind-a-tender
Official notice URLNot published
Tender statusplanned
Procurement methodNot published
Procurement method detailsNot published
Main procurement categorygoods
Above thresholdNot published
Legal basis32014L0024
Tender period: startNot published
Tender period: endNot published
Expression of interest deadlineNot published
Enquiry deadlineNot published
Award period: startNot published
Award period: endNot published
Submission method detailsNot published
Submission languagesNot published
Electronic catalogue policyNot published
Total tender valueNot published
Tender lots in source1
Tender items in source1
Tender documents in source0
Awards in latest release0
Contracts in latest release0
Parties in latest release1

Notice history

DateEventReference
14 Nov 2024planning036869-2024

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON
{
  "id": "036869-2024",
  "tag": [
    "planning"
  ],
  "date": "2024-11-14T14:41:45Z",
  "ocid": "ocds-h6vhtk-04b679",
  "buyer": {
    "id": "GB-FTS-423",
    "name": "Procurement and Logistics Service"
  },
  "tender": {
    "id": "ocds-h6vhtk-04b679",
    "lots": [
      {
        "id": "1",
        "status": "planned",
        "description": "This is a Prior Information Notice published by the Business Services Organisation (BSO), Procurement and Logistics Service (PaLS) (the Authority), on behalf of our Client - the Belfast Health and Social Care Trust (BHSCT), to enter into pre-market engagement with interested suppliers, as PaLS are commencing work for the provision of a solution for next generation sequencing for the Regional Molecular Diagnostics Service (RMDS) which includes: Genetics, Haematology, Microbiology, Histocompatibility and Immunogenetics Laboratories based in the BHSCT.\nThe RMDS offers services for Germline and Somatic testing to improve diagnosis, treatment options and management of patients with cancer, haematological conditions and rare genetic disorders. The germline service is divided into Constitutional Cytogenetics and Molecular Genetics, and the somatic service consists of a solid tumour and hematological malignancies section.\nThe objectives of the Product Awareness Sessions are to: -\n* Gain initial supplier interest in supply and delivery / provision of the Next Generation Sequence Solution.\n* Seek interested parties to complete a site visit to RMDS to view current arrangements and floorplans.\n* Gain insight on the market possibilities and potential innovative solutions.\n* Establish how market ready suppliers currently are.\n* Ascertain how suppliers can assist the HSCNI to ensure Health and Safety Standards are met and to ensure compliance with all relevant and future legislation.\n* Understand risks and potential issues relating to supply and delivery of Next Generation Sequence Solution.\n* Gain a better understanding of the feasibility of the HSCNI requirements and the most appropriate procurement approach to follow. Additional information: Site Visits: Interested suppliers are requested to visit the client site and is mandatory to understand the client’s infrastructure at the site. Advance arrangement is necessary. The Client has limited capacity to facilitate site visits; therefore, places will be restricted and it may not be possible to accommodate all interested suppliers. Sessions will be allocated on a first come first served basis. Market Engagement Questionnaire: Any interested suppliers are asked to complete and submit the associated questionnaire.. The Product Awareness Sessions will be an opportunity for suppliers to present to a panel of Next Generation Sequencing professionals. Interested suppliers will be invited to a product awareness session. This session will be scheduled to last approximately 60 minutes per presenting organisation and presenters will be required to:- a) Provide a video demonstration of the physical and practical functioning of the proposed solution. This video should last no more than 10 minutes. b) Provide an oral presentation on their equipment, testing capabilities and software to attendees, including IT connectivity capabilities. c). To be available for responding to questions or clarifications from those in attendance following the presentation, covering all aspects of system operation, connectivity, installation, commissioning, training, and after-sales servicing, including contingency services. The oral presentation will be scheduled to last approximately 30 minutes per presenting organisation, and should cover all aspects of functionality, including testing capabilities, turnaround time, throughput, sample processing, compatibility of sample and media types, consumables, quality management, ICT connectivity, software, aftersales support, and contingency. The participating organisations should be available for questions or clarification from those in attendance following the oral presentation, covering all aspects of system operation, connectivity, installation, commissioning, training, and after-sales servicing, including contingency services. Product awareness sessions are scheduled to take place in person, on Wednesday 15th & Friday 17th January 2025. It is likely that the Client will only be able to facilitate 2 days of supplier engagement sessions; therefore,. places will be limited, and it may not be possible to accommodate all interested suppliers. Sessions will be allocated on a first come first served basis. The venue for the product awareness session will be at Belfast City Hospital. To register interest, interested suppliers must complete the Declaration of interest form in Appendix 2, as detailed in the Declaration of Interest document once requested. Specific appointment times will be communicated to each supplier following this date.. What you need to do now: . a) If not registered on eTendersNI, do so on the website www.eTendersNI.gov.uk Go to the 'Suppliers new to eTendersNI' section and follow the registration process. Potential tenderers will be required to register against the relevant CPV codes applicable to them to ensure they receive email alerts regarding specific areas of interest. If already registered. b) Potential tenderers should review their contact details to ensure the information is up to date. Assistance is available from eTendersNI Helpdesk, telephone number: 08002404545.. c) Declare your interest in this Supplier engagement exercise by sending an email to palsgransha.sourcing@hscni.net requesting a Declaration of Interest pack.. d) Complete the Declaration of Interest form Appendix 1. e) Submit your completed Declaration of Interest form Appendix 1 by email to palsgransha.sourcing@hscni.net before the deadline at 15.00 hrs Thursday 28th November 2024.. f) Ensure that you will be available to attend site visits W.C. 9th December 2024. g) Complete the Declaration of Interest form Appendix 2 to participate in Product Awareness Session. h) Submit your completed Declaration of Interest form Appendix 2 to participate in Product Awareness Session before the deadline at 15:00 hrs Thursday 19th December 2024.. i) Complete the Market Engagement Questionnaire form. j) Submit the Market Engagement Questionnaire form by 15:00 on Thursday 19th December 2024.. k) Ensure that you will be available to attend the Supplier product awareness Session(s) on Wednesday 15th January 2025 and Friday 17th January 2025 in Belfast City Hospital and be able to present.."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKN"
          }
        ]
      }
    ],
    "title": "NEXT GENERATION SEQUENCING SOLUTION - PIN",
    "status": "planned",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "This is a Prior Information Notice published by the Business Services Organisation (BSO), Procurement and Logistics Service (PaLS) (the Authority), on behalf of our Client - the Belfast Health and Social Care Trust (BHSCT), to enter into pre-market engagement with interested suppliers, as PaLS are commencing work for the provision of a solution for next generation sequencing for the Regional Molecular Diagnostics Service (RMDS) which includes: Genetics, Haematology, Microbiology and Histocompatibility and Immunogenetics Laboratories based in the BHSCT.",
    "communication": {
      "futureNoticeDate": "2025-05-01T00:00:00+01:00"
    },
    "classification": {
      "id": "33000000",
      "scheme": "CPV",
      "description": "Medical equipments, pharmaceuticals and personal care products"
    },
    "mainProcurementCategory": "goods"
  },
  "parties": [
    {
      "id": "GB-FTS-423",
      "name": "Procurement and Logistics Service",
      "roles": [
        "buyer",
        "centralPurchasingBody"
      ],
      "address": {
        "region": "UKN",
        "locality": "Belfast",
        "postalCode": "BT12 6HU",
        "countryName": "United Kingdom",
        "streetAddress": "77 Boucher Crescent"
      },
      "details": {
        "url": "https://etendersni.gov.uk/epps",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "Procurement and Logistics Service"
      },
      "contactPoint": {
        "email": "palsgransha.sourcing@hscni.net"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}
Complete JSON history (1 releases)
14 Nov 2024 · 036869-2024 · planning
{
  "id": "036869-2024",
  "tag": [
    "planning"
  ],
  "date": "2024-11-14T14:41:45Z",
  "ocid": "ocds-h6vhtk-04b679",
  "buyer": {
    "id": "GB-FTS-423",
    "name": "Procurement and Logistics Service"
  },
  "tender": {
    "id": "ocds-h6vhtk-04b679",
    "lots": [
      {
        "id": "1",
        "status": "planned",
        "description": "This is a Prior Information Notice published by the Business Services Organisation (BSO), Procurement and Logistics Service (PaLS) (the Authority), on behalf of our Client - the Belfast Health and Social Care Trust (BHSCT), to enter into pre-market engagement with interested suppliers, as PaLS are commencing work for the provision of a solution for next generation sequencing for the Regional Molecular Diagnostics Service (RMDS) which includes: Genetics, Haematology, Microbiology, Histocompatibility and Immunogenetics Laboratories based in the BHSCT.\nThe RMDS offers services for Germline and Somatic testing to improve diagnosis, treatment options and management of patients with cancer, haematological conditions and rare genetic disorders. The germline service is divided into Constitutional Cytogenetics and Molecular Genetics, and the somatic service consists of a solid tumour and hematological malignancies section.\nThe objectives of the Product Awareness Sessions are to: -\n* Gain initial supplier interest in supply and delivery / provision of the Next Generation Sequence Solution.\n* Seek interested parties to complete a site visit to RMDS to view current arrangements and floorplans.\n* Gain insight on the market possibilities and potential innovative solutions.\n* Establish how market ready suppliers currently are.\n* Ascertain how suppliers can assist the HSCNI to ensure Health and Safety Standards are met and to ensure compliance with all relevant and future legislation.\n* Understand risks and potential issues relating to supply and delivery of Next Generation Sequence Solution.\n* Gain a better understanding of the feasibility of the HSCNI requirements and the most appropriate procurement approach to follow. Additional information: Site Visits: Interested suppliers are requested to visit the client site and is mandatory to understand the client’s infrastructure at the site. Advance arrangement is necessary. The Client has limited capacity to facilitate site visits; therefore, places will be restricted and it may not be possible to accommodate all interested suppliers. Sessions will be allocated on a first come first served basis. Market Engagement Questionnaire: Any interested suppliers are asked to complete and submit the associated questionnaire.. The Product Awareness Sessions will be an opportunity for suppliers to present to a panel of Next Generation Sequencing professionals. Interested suppliers will be invited to a product awareness session. This session will be scheduled to last approximately 60 minutes per presenting organisation and presenters will be required to:- a) Provide a video demonstration of the physical and practical functioning of the proposed solution. This video should last no more than 10 minutes. b) Provide an oral presentation on their equipment, testing capabilities and software to attendees, including IT connectivity capabilities. c). To be available for responding to questions or clarifications from those in attendance following the presentation, covering all aspects of system operation, connectivity, installation, commissioning, training, and after-sales servicing, including contingency services. The oral presentation will be scheduled to last approximately 30 minutes per presenting organisation, and should cover all aspects of functionality, including testing capabilities, turnaround time, throughput, sample processing, compatibility of sample and media types, consumables, quality management, ICT connectivity, software, aftersales support, and contingency. The participating organisations should be available for questions or clarification from those in attendance following the oral presentation, covering all aspects of system operation, connectivity, installation, commissioning, training, and after-sales servicing, including contingency services. Product awareness sessions are scheduled to take place in person, on Wednesday 15th & Friday 17th January 2025. It is likely that the Client will only be able to facilitate 2 days of supplier engagement sessions; therefore,. places will be limited, and it may not be possible to accommodate all interested suppliers. Sessions will be allocated on a first come first served basis. The venue for the product awareness session will be at Belfast City Hospital. To register interest, interested suppliers must complete the Declaration of interest form in Appendix 2, as detailed in the Declaration of Interest document once requested. Specific appointment times will be communicated to each supplier following this date.. What you need to do now: . a) If not registered on eTendersNI, do so on the website www.eTendersNI.gov.uk Go to the 'Suppliers new to eTendersNI' section and follow the registration process. Potential tenderers will be required to register against the relevant CPV codes applicable to them to ensure they receive email alerts regarding specific areas of interest. If already registered. b) Potential tenderers should review their contact details to ensure the information is up to date. Assistance is available from eTendersNI Helpdesk, telephone number: 08002404545.. c) Declare your interest in this Supplier engagement exercise by sending an email to palsgransha.sourcing@hscni.net requesting a Declaration of Interest pack.. d) Complete the Declaration of Interest form Appendix 1. e) Submit your completed Declaration of Interest form Appendix 1 by email to palsgransha.sourcing@hscni.net before the deadline at 15.00 hrs Thursday 28th November 2024.. f) Ensure that you will be available to attend site visits W.C. 9th December 2024. g) Complete the Declaration of Interest form Appendix 2 to participate in Product Awareness Session. h) Submit your completed Declaration of Interest form Appendix 2 to participate in Product Awareness Session before the deadline at 15:00 hrs Thursday 19th December 2024.. i) Complete the Market Engagement Questionnaire form. j) Submit the Market Engagement Questionnaire form by 15:00 on Thursday 19th December 2024.. k) Ensure that you will be available to attend the Supplier product awareness Session(s) on Wednesday 15th January 2025 and Friday 17th January 2025 in Belfast City Hospital and be able to present.."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKN"
          }
        ]
      }
    ],
    "title": "NEXT GENERATION SEQUENCING SOLUTION - PIN",
    "status": "planned",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "This is a Prior Information Notice published by the Business Services Organisation (BSO), Procurement and Logistics Service (PaLS) (the Authority), on behalf of our Client - the Belfast Health and Social Care Trust (BHSCT), to enter into pre-market engagement with interested suppliers, as PaLS are commencing work for the provision of a solution for next generation sequencing for the Regional Molecular Diagnostics Service (RMDS) which includes: Genetics, Haematology, Microbiology and Histocompatibility and Immunogenetics Laboratories based in the BHSCT.",
    "communication": {
      "futureNoticeDate": "2025-05-01T00:00:00+01:00"
    },
    "classification": {
      "id": "33000000",
      "scheme": "CPV",
      "description": "Medical equipments, pharmaceuticals and personal care products"
    },
    "mainProcurementCategory": "goods"
  },
  "parties": [
    {
      "id": "GB-FTS-423",
      "name": "Procurement and Logistics Service",
      "roles": [
        "buyer",
        "centralPurchasingBody"
      ],
      "address": {
        "region": "UKN",
        "locality": "Belfast",
        "postalCode": "BT12 6HU",
        "countryName": "United Kingdom",
        "streetAddress": "77 Boucher Crescent"
      },
      "details": {
        "url": "https://etendersni.gov.uk/epps",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "Procurement and Logistics Service"
      },
      "contactPoint": {
        "email": "palsgransha.sourcing@hscni.net"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}